期刊文献+

凋亡抑制蛋白c—FLIP在银屑病患者外周血和皮损中的表达 被引量:1

Expression of cellular FLICE-inhibitory protein in peripheral blood and lesions of patients with psoriasis
原文传递
导出
摘要 目的探讨凋亡抑制蛋白c—FLIP在寻常性银屑病患者外周血和皮损中的表达和分布情况。方法采用流式细胞仪检测30例寻常性银屑病患者和20例正常人对照组外周血T细胞和B细胞内c—FLIP蛋白表达阳性率,采用免疫组化方法检测c—FLIP蛋白在其皮损中的表达。结果进行期银屑病患者外周血T细胞内c—FLIP表达(6.32%±1.17%)明显高于恢复期患者(2.64%±0.74%,P〈0.01)和正常人对照组(2.28%±0.54%,P〈0.05)。而其在外周血B细胞内的表达3组间差异无统计学意义,3组分别为0.78%±0.16%,0.71%±0.32%,0.69%±0.18%,P值均〉0.05。c—FLIP蛋白在进行期银屑病患者皮损中的表达(89.73±5.24)明显高于恢复期(117.40±7.50,P〈0.05)和正常人对照组(121.58±7.93,P〈0.01),恢复期患者和正常人对照组之间差异无统计学意义(P〉0.05)。结论凋亡抑制蛋白c—FLIP在进行期银屑病患者的外周血T细胞和皮损内明显高表达,可能参与银屑病患者T细胞的增殖。 Objective To investigate the expression and distribution of cellular FLICE-inhibimry protein (c-FLIP) in peripheral blood and lesions of psoriatic patients. Methods Peripheral blood and skin samples were obtained from 30 patients with psoriasis vulgaris and 20 normal consols. Flow cytometry was used to detect intracellular c-FLIP protein in peripheral T and B lymphocytes, immunohistochemistry to examine the expression of c-FLIP in lesional tissue. Results Based on the positivity rate of c-FLIP, there was a significant increase in T lymphocytes in active psoriasis compared with regressive psoriasis and normal controls (6.32% ± 1.17% vs 2.64% ± 0.74% and 2.28% ± 0.54%, P〈 0.01 and 0.05, respectively), while no significant difference was found in B lymphocytes among these three groups (0.78% ± 0.16%, 0.71% ± 0.32%, 0.69% ± 0.18%, respectively, P 〉 0.05 ). The expression intensity of c-FLIP in keratinocytes was also higher in active psoriasis than in regressive psoriasis and normal controls (89.73 ± 5.24 vs 117.40 ± 7.50, 121.58 ± 7.93, P 〈 0.01 and 0.05 respectively), and there was no difference between regressive psoriasis and normal controls (P 〉 0.05 ). Conclusions c-FLIP is highly expressed in lesions and peripheral T lymphocytes of patients with active psoriasis, suggesting the possible involvement of c-FLIP in the proliferation of T lymphocytes in psoriasis.
出处 《中华皮肤科杂志》 CAS CSCD 北大核心 2008年第6期377-379,共3页 Chinese Journal of Dermatology
关键词 银屑病 凋亡抑制蛋白质类 细胞凋亡 Psoriasis Apoptosis proteins inhibitor Apoptosis
  • 相关文献

参考文献10

  • 1Schmitz I, Weyd H, Krueger A, et al. Resistance of short term activated T cells to CD95-mediated apoptosis correlates with de novo protein synthesis of c-FLIPshort. J Immunol, 2004, 172 (4): 2194-2200.
  • 2Krueger JG. The immunologic basis for the treatment of psoriasis with new biologic agents. J Am Acad Dermatol, 2002, 46( 1): 1-23.
  • 3Lebwohl M. Psoriasis. Lancet, 2003, 361(9364): 1197-1204.
  • 4Nickoloff BJ, Nestle FO. Recent insights into the immunopathogenesis of psoriasis provide new therapeutic opportunities. J Clin Invest, 2004, 113( 12): 1664-1675.
  • 5Bowcock AM, Krueger JG. Getting under the skin: the immunogenetics of psoriasis. Nat Rev Immunol, 2005, 5(9): 699-711.
  • 6Schon MP, Boehncke WH. Psoriasis. N Engl J Med, 2005, 352 ( 18): 1899-1912.
  • 7Gaspari AA. Innate and adaptive immunity and the pathophysiology of psoriasis. J Am Acad Dermatol, 2006, 54 (3 Suppl 2): S67-S80.
  • 8黄长征,陈爱军,涂亚庭,刘志香.CD28/B7在银屑病皮损及外周血淋巴细胞中的表达[J].中华皮肤科杂志,2004,37(10):589-591. 被引量:5
  • 9Bai S, Liu H, Chen KH, et al. NF-KB-regulated expression of cellular FLIP protects rheumatoid arthritis synovial fibroblasts from tumour necrosis factor α-mediated apoptosis. Arthritis Rheu, 2004, 50( 12): 3844-3855.
  • 10Wang J, Lobito AA, Shen F, et al. Inhibition of Fas-mediated apoptosis by the B cell antigen receptor through c-FLIP. Eur J Immunol, 2000, 30( 1 ): 155-163.

二级参考文献9

  • 1Garcia RL, Coltrera MD, Gown AM.Analysis of proliferative grade using anti-PCNA/cyclin monoclonal antibodies in fixed, embedded tissues. Comparison with flow cytometric analysis. Am J Pathol,1989, 134:733-739.
  • 2Ferenczi K, Burack L, Pope M, et al. CD69, HLA-DR and the IL-2R identify persistently activated T cells in psoriasis vulgaris lesional skin: blood and skin comparisons by flow cytometry. J Autoimmun, 2000, 14:63-78.
  • 3Nickoloff B J, Nestle FO, Zheng XG, et al. T lymphocytes in skin lesions of psoriasis and mycosis fungoides express B7-1: a ligand for CD28.Blood, 1994, 83:2580-2586.
  • 4Geissmann F, Prost C, Monnet JP, et al. Transforming growth factor betal, in the presence of granulocyte/macrophage colony-stimulating factor and interleukin 4, induces differentiation of human peripheral blood monocytes into dendritic Langerhans cells. J Exp Med,1998, 187:961-966.
  • 5Yu Y, Tang L, Wang J, et al. Psoriatic lesional keratinocytes promote the maturation of human monocyte-derived Langerhans cells.Dermatology, 2002, 204: 94-99.
  • 6Zhu K, Mrowietz U. Inhibition of dendritic cell differentiation by fumaric acid esters.J Invest Dermatol, 2001, 116:203-208.
  • 7Gottlieb AB, Lebwohl M, Totoritis MC, et al. Clinical and histologic response to single-dose treatment of moderate to severe psoriasis with an anti-CD80 monoclonal antibody. J Am Acad Dermatol,2002, 47: 692-700.
  • 8Abrams JR, Kelley SL, Hayes E, et al. Blockade of T lymphocyte costimulation with cytotoxic T lymphocyte-associated antigen 4-immunoglobulin (CTLA4Ig) reverses the cellular pathology of psoriatic plaques, including the activation of keratinocytes, dendritic cells,and endothelial cells. J Exp Med, 2000, 192:681-694.
  • 9朱可建,周伟芳,劳力民,郑敏.银屑病患者外周血单核细胞向树突状细胞分化能力的研究[J].中华皮肤科杂志,2002,35(2):88-90. 被引量:6

共引文献4

同被引文献22

  • 1Lowes MA,Kikuchi T,Fuentes-Duculan J,et al.Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells[J].J Invest Dermatol,2008,128(5):1207-1211.
  • 2Terada M,Tsutsui H,Imai Y,et al.Contribution of IL-18 to atopic-dermatitis-like skin inflammation induced by Staphylococcus aureus product in mice[J].Proc Natl Acad Sci U S A,2006,103(23):8816-8821.
  • 3Arking DE,Chakravarti A.Understanding cardiovascular disease through the lens of genome-wide association studies[J].Trends Genet,2009,25(9):387-394.
  • 4Johnston A,Xing X,Guzman AM,et al.IL-1F5,-F6,-F8,and-F9:a novel IL-1 family signaling system that is active in psoriasis and promotes keratinocyte antimicrobial peptide expression[J].J Immunol,2011,186(4):2613-2622.
  • 5Hirotsu C,Rydlewski M,Araújo MS,et al.Sleep loss and cytokines levels in an experimental model of psoriasis[J/OL].PLoS One,2012,7 (11):e51183[2012-11-30].http://www.plosone.org/article/info% 3Adoi% 2F10.1371% 2Fjournal.pone.0051183.
  • 6Enerback C.Soluble biomarkers in psoriasis[J].Eur J Dermatol,2011,21 (6):844-850.
  • 7Pola R.Inflammatory markers for ischaemic stroke[J].Thromb Haemost,2009,101 (5):800-801.
  • 8Stumpf C,Auer C,Yilmaz A,et al.Serum levels of the Th1 chemoattractant interferon-gamma-inducible protein (IP) 10 are elevated in patients with essential hypertension[J].Hypertens Res,2011,34(4):484-488.
  • 9Yamamoto T.Angiogenic and inflammatory properties of psoriatic arthritis[J].ISRN Dermatol,2013,2013:630620.
  • 10Quatresooz P,Hermanns-L(e) T,Piérard GE,et al.Ustekinumab in psoriasis immunopathology with emphasis on the Th17-IL23 axis:a primer[J].J Biomed Biotechnol,2012,2012:147413.

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部